TGM2高表达对GES1细胞生长增殖的影响(3)
Katoh H, Ishikawa S. Genomic pathobiology of gastric carcinoma[J].Pathol Int. 2017,67(2):63-71.
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin. 2016,66(2):115-132.
張志伟, 汤国辉, 赵强, 等. AKT-p27Kip1-Cyclin E在胃癌组织中的表达及意义[J].世界华人消化杂志,2011,19(21):2233-2240.
张志伟. 胃粘膜上皮癌变相关蛋白质分子的筛选与鉴定[D]. 2015, 南华大学博士学位论文.
Pietsch M, Wodtke R, Pietzsch J, et al. Tissue transglutaminase:an emerging target for therapy and imaging[J]. Bioorg Med Chem Lett. 2013, 23(24):6528-6543.
Li B, Cerione RA, Antonyak M. Tissue transglutaminase and its role in human cancer progression[J]. Adv Enzymol Relat Areas Mol Biol. 2011, 78:247-293.
Budillon A, Carbone C, Di Gennaro E. Tissue transglutaminase:a new target to reverse cancer drug resistance[J]. Amino Acids. 2013, 44(1):63-72.
Nadalutti C, Viiri KM, Kaukinen K, et al. Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis[J]. Cell Prolif. 2011, 44(1):49-58.
Jiang D, Ying W, Lu Y, et al. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis[J]. Proteomics. 2003, 3(5):724-737.
Antonyak MA, Miller AM, Jansen JM, et al. Augmentation of tissue transglutaminase expression and activation by epi-dermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells[J]. J Biol Chem. 2004, 79(40):41461-41467.
Fu J, Yang QY, Sai K, et al. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells[J]. Neuro Oncol. 2013,15(10):1353-65.
Obinata A, Osakabe K, Yamaguchi M, et al. Tgm2/Gh, Gbx1 and TGF-beta are involved in retinoic acid-induced transdifferentiation from epidermis to mucosal epithelium[J]. Int J Dev Biol. 2011,55(10-12):933-43., 百拇医药(吴霞 艾小红 彭顺清)
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin. 2016,66(2):115-132.
張志伟, 汤国辉, 赵强, 等. AKT-p27Kip1-Cyclin E在胃癌组织中的表达及意义[J].世界华人消化杂志,2011,19(21):2233-2240.
张志伟. 胃粘膜上皮癌变相关蛋白质分子的筛选与鉴定[D]. 2015, 南华大学博士学位论文.
Pietsch M, Wodtke R, Pietzsch J, et al. Tissue transglutaminase:an emerging target for therapy and imaging[J]. Bioorg Med Chem Lett. 2013, 23(24):6528-6543.
Li B, Cerione RA, Antonyak M. Tissue transglutaminase and its role in human cancer progression[J]. Adv Enzymol Relat Areas Mol Biol. 2011, 78:247-293.
Budillon A, Carbone C, Di Gennaro E. Tissue transglutaminase:a new target to reverse cancer drug resistance[J]. Amino Acids. 2013, 44(1):63-72.
Nadalutti C, Viiri KM, Kaukinen K, et al. Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis[J]. Cell Prolif. 2011, 44(1):49-58.
Jiang D, Ying W, Lu Y, et al. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis[J]. Proteomics. 2003, 3(5):724-737.
Antonyak MA, Miller AM, Jansen JM, et al. Augmentation of tissue transglutaminase expression and activation by epi-dermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells[J]. J Biol Chem. 2004, 79(40):41461-41467.
Fu J, Yang QY, Sai K, et al. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells[J]. Neuro Oncol. 2013,15(10):1353-65.
Obinata A, Osakabe K, Yamaguchi M, et al. Tgm2/Gh, Gbx1 and TGF-beta are involved in retinoic acid-induced transdifferentiation from epidermis to mucosal epithelium[J]. Int J Dev Biol. 2011,55(10-12):933-43., 百拇医药(吴霞 艾小红 彭顺清)